Overall Technical outlook

Price Summary

NATCO Pharma Limited's stock began trading at 1106.9 on 2026-04-09, soared to 1128.0, dipped to 1097.15, and finished the day 1.52% higher at 1123.7, with 866787 shares exchanged.
The stock reached its highest price of 1123.7 and lowest price of 0.0 over the last 52 weeks.
Analysts' predictions indicate that NATCOPHARM's future price will be between 712.0 and 1480.0, with a mean price expectation of approximately 970.36365.

Technicals


Aroon: Aroon's bullish trend persists, with Aroon Up staying at the 100 level. This indicates strong market momentum, but further analysis using additional indicators is necessary to determine the trend's sustainability and future direction.
NATCOPHARM aroon 59449c
Aroon chart for NATCO Pharma Limited


Bol. Bands: The BOLL BANDS is showing a neutral stance, with no definitive indication of an upward or downward trend for NATCOPHARM. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
NATCOPHARM bbands 59449c
Bolinger Bands chart for NATCO Pharma Limited


Parabolic SAR: The PSAR for NATCOPHARM maintains its bullish outlook, setting a strong support level that could underpin further gains. This suggests that the market is likely to continue its upward trajectory, with the established support providing a safety net for ongoing bullish momentum.
NATCOPHARM psar 59449c
Parabolic Stop and Reverse chart for NATCO Pharma Limited


Stochastic: The stochastic indicator for NATCOPHARM shows a bullish signal, with the K-line positioned above the D-line and also above the 80 mark. This suggests strong upward momentum, indicating that the market may continue to trend higher. Traders might view this as a sign of continued strength and potential buying opportunities.
NATCOPHARM stoch 59449c
Stochastic chart for NATCO Pharma Limited


Tripple Moving Agerage: The moving averages are aligned in favor of a bullish trend for NATCOPHARM, with the 20-50-100 aggregates all sloping upward. This configuration suggests that market momentum is increasing, reinforcing the likelihood of further price gains. Traders may consider this a strong indication to enter or hold their positions in anticipation of continued growth.
NATCOPHARM trippleSMA 59449c
Tripple SMA chart for NATCO Pharma Limited


When evaluating a company, it is crucial to examine its fundamentals, including its financial statements, management structure, and market position. Additionally, understanding the broader industry trends, competition, and regulatory landscape helps to create a well-rounded view. By assessing both the company's internal factors and the external environment in which it operates, you can extract more valuable insights from its technical performance, such as stock price movements and trading patterns.